Clsi E Coli Breakpoints 2024. Aeruginosa led clsi to an update of the aminoglycoside breakpoints (see table 2). Prior to 2022, clsi published investigational breakpoints for s.

Breakpoints are part of a system for categorising microorganisms as susceptible (s and i) and resistant (r) to agents approved for use in the treatment of infectious diseases. Extensive analysis of pk/pd, clinical outcomes, and current susceptibility profiles for enterobacterales and p.